Pharmafile Logo
Pharmafocus logo
Advanced Search
mikem

Mike Mallinson joins The Access Partnership

November 1, 2012
Medical Communications, Sales and Marketing Mark Mallinson, The Access Partnership

Mike Mallinson has been appointed to lead communications firm The Access Partnership in the role of president. Mallinson is a …

Appointment
gsk image

GSK hit by European austerity again

November 1, 2012
Sales and Marketing Europe, GSK, Q3, austerity

GlaxoSmithKline suffered in the third quarter as sales fell 5% due to generic competition and austerity measures in Europe.Exceptional sales …

News

Novartis to build $500 million biotech facility in Singapore

November 1, 2012
Manufacturing and Production, Sales and Marketing Jimenez, M&P, Novartis, Singapore

Novartis is overseeing the construction of a biotechnology facility in Singapore that is the result of a $500m investment injection. …

News
peter_levantis

Inspired Science appoints principal medical writer

October 31, 2012
Medical Communications, Sales and Marketing Inspired Science, Peter Levantis

Med comms firm Inspired Science has announced the appointment of Dr Peter Levantis as principal medical writer. In this newly …

Appointment
sanofi image

Diabetes softens generics blow for Sanofi

October 30, 2012
Sales and Marketing Eloxatin, Plavix, Sanofi, diabetes, emerging markets, patent cliff

Sanofi has unveiled its results for the third quarter, with news that the damage done by patent expiries has not …

News

Lilly appoints new chief ethics and compliance officer and senior VP

October 30, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Melissa Barnes, lilly

Eli Lilly has announced that Melissa Barnes will be promoted to chief ethics and compliance officer and senior vice president …

Appointment

Canada latest country to suspend sales of Novartis vaccines

October 30, 2012
Manufacturing and Production Canada, Novartis, vaccines

Canada has said it will suspend sales of two flu vaccines made by Novartis – following in the footsteps of …

News

Shionogi and ViiV strike new HIV deal

October 30, 2012
Research and Development, Sales and Marketing Atripla, Dolutegravir, HIV, Shionogi, ViiV

HIV specialist firm ViiV Healthcare has announced a new deal with Japan’s Shionogi on a promising new treatment. ViiV Healthcare …

News

Pharmalink AB strengthens senior management

October 30, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Heather Cook, Marek Poszepczynski, Pharmalink AB

Pharmalink AB has appointed Heather Cook as director of Regulatory Affairs and Marek Poszepczynski as director of Business Development. Cook …

Appointment
Boehringer image

Boehringer to increase production of Respimat inhaler

October 30, 2012
Manufacturing and Production Boehringer Ingelheim, Respimat SMI, Soft Mist

Boehringer Ingelheim is investing €85 million in manufacturing capacity for its Respimat Soft Mist Inhaler in the face of growing …

News
Patheon image

Patheon buys softgel specialist Banner in $255m deal

October 30, 2012
Manufacturing and Production Capsugel, Patheon, banner pharmacaps

Patheon has forged a deal to acquire gelatin capsule specialist Banner Pharmacaps for $255 million in a deal that boosts …

News
teva image

Teva’s CML drug approved

October 29, 2012
Research and Development, Sales and Marketing FDA, Synribo, Teva

Teva’s new treatment for chronic myeloid leukemia Synribo has been approved by the FDA. Synribo (omacetaxine mepesuccinate) is an injectable …

News

Almirall welcomes UCB head into Board of directors

October 29, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Almirall, Gerhard Mayr

Almirall has approved the appointment of Gerhard Mayr as a new independent member to its Board of directors. He is …

Appointment
Novartis image

EU countries suspend sales of Novartis flu vaccines

October 29, 2012
Manufacturing and Production, Sales and Marketing EU, Novartis, vaccines

Contamination of Novartis flu vaccines with white particles has resulted in regulatory actions from various authorities in the EU, including …

News
Portsmouth

The NHS revolution – one wave at a time

October 26, 2012
Sales and Marketing CCGs, NHS, pharma-NHS partnerships

 The first group of prospective Clinical Commissioning Groups (CCGs) will have to wait a little longer to hear if they …

Feature

Turning business intelligence managers into business performance leaders

October 26, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, MSI, business leaders, intelligence

Never before have business intelligence people played such a leading role in the marketing planning process. For those who view …

Feature
Astrazeneca image

Sharp fall for AstraZeneca

October 26, 2012
Sales and Marketing AstraZeneca, Brennan, Q3, Soriot

AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …

News
pat_mccauley_214x164

Astellas announces compliance officer for the Americas

October 26, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Astellas, McCauley

Astellas recently named J. Patrick McCauley Jr, a longtime pharmaceutical industry veteran and Astellas employee, to the post of Regional …

Appointment
Shire image

Shire poaches new head from Bayer

October 26, 2012
Sales and Marketing Angus Russell, Flemming Omskov, Shire

Flemming Ornskov, currently chief marketing officer at Bayer, is to take over at Dublin-based Shire Pharmaceuticals next year. He will …

News
FDA image

Contaminated steroids blamed for deadly meningitis outbreak

October 25, 2012
Manufacturing and Production FDA, GMP, NECC

As many as 14,000 patients may have been exposed to contaminated steriods that have led to 23 deaths due to …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026